Evidence map›Paper›PMID 28193090›Full record

ArticleAIDS research and human retroviruses2017

Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.

Neha S Shah, Yen T Duong, Linh-Vi Le, Nguyen Anh Tuan, Bharat S Parekh, Hoang Thi Thanh Ha, Quang Duy Pham, Cao Thi Thu Cuc, Trudy Dobbs, Tran Hong Tram and 7 more

Abstract readEvaluation Study
In one paragraph

Article in AIDS research and human retroviruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Neha S Shah1 Centers for Disease Control and Prevention , Atlanta, Georgia .
Yen T Duong1 Centers for Disease Control and Prevention , Atlanta, Georgia .
Linh-Vi Le2 Centers for Disease Control and Prevention , Hanoi, Vietnam .
Nguyen Anh Tuan3 National Institute of Hygiene and Epidemiology , Hanoi, Vietnam .
Bharat S Parekh1 Centers for Disease Control and Prevention , Atlanta, Georgia .
Hoang Thi Thanh Ha3 National Institute of Hygiene and Epidemiology , Hanoi, Vietnam .
Quang Duy Pham4 Ho Chi Minh City Pasteur Institute , Ho Chi Minh City, Vietnam .
Cao Thi Thu Cuc4 Ho Chi Minh City Pasteur Institute , Ho Chi Minh City, Vietnam .
Trudy Dobbs1 Centers for Disease Control and Prevention , Atlanta, Georgia .
Tran Hong Tram3 National Institute of Hygiene and Epidemiology , Hanoi, Vietnam .
Truong Thi Xuan Lien4 Ho Chi Minh City Pasteur Institute , Ho Chi Minh City, Vietnam .
Nick Wagar1 Centers for Disease Control and Prevention , Atlanta, Georgia .
Chunfu Yang1 Centers for Disease Control and Prevention , Atlanta, Georgia .
Amy Martin1 Centers for Disease Control and Prevention , Atlanta, Georgia .
Mitchell Wolfe2 Centers for Disease Control and Prevention , Hanoi, Vietnam .
Nguyen Tran Hien3 National Institute of Hygiene and Epidemiology , Hanoi, Vietnam .
Andrea A Kim1 Centers for Disease Control and Prevention , Atlanta, Georgia .
Centers for Disease Control and Prevention · USNational Institute Of Hygiene And Epidemiology · VNInstitut Pasteur in Ho Chi Minh City · VN

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Laboratory tests that can distinguish recent from long-term HIV infection are used to estimate HIV incidence in a population, but can potentially misclassify a proportion of long-term HIV infections as recent. Correct application of an assay requires determination of the proportion false recents (PFRs) as part of the assay characterization and for calculating HIV incidence in a local population using a HIV incidence assay. From April 2009 to December 2010, blood specimens were collected from HIV-infected individuals attending nine outpatient clinics (OPCs) in Vietnam (four from northern and five from southern Vietnam). Participants were living with HIV for ≥1 year and reported no antiretroviral (ARV) drug treatment. Basic demographic data and clinical information were collected. Specimens were tested with the BED capture enzyme immunoassay (BED-CEIA) and the Limiting-antigen (LAg)-Avidity EIA. PFR was estimated by dividing the number of specimens classified as recent by the total number of specimens; 95% confidence intervals (CI) were calculated. Specimens that tested recent had viral load testing performed. Among 1,813 specimens (north, n = 942 and south, n = 871), the LAg-Avidity EIA PFR was 1.7% (CI: 1.2-2.4) and differed by region [north 2.7% (CI: 1.8-3.9) versus south 0.7% (CI: 0.3-1.5); p = .002]. The BED-CEIA PFR was 2.3% (CI: 1.7-3.0) and varied by region [north 3.4% (CI: 2.4-4.7) versus south 1.0% (CI: 0.5-1.2), p < .001]. Excluding specimens with an undetectable VL, the LAg-Avidity EIA PFR was 1.2% (CI: 0.8-1.9) and the BED-CEIA PFR was 1.7% (CI: 1.2-2.4). The LAg-Avidity EIA PFR was lower than the BED-CEIA PFR. After excluding specimens with an undetectable VL, the PFR for both assays was similar. A low PFR should facilitate the implementation of the LAg-Avidity EIA for cross-sectional incidence estimates in Vietnam.

Indexed as

Diagnostic ErrorsEpidemiologic MethodsAdolescentAdultAgedCross-Sectional StudiesHIV AntigensHIV InfectionsHumansImmunoenzyme TechniquesIncidenceMiddle AgedSerologic TestsVietnamYoung AdultHIV AntigensepidemiologyHIVincidenceprevention

Identifiers

PMID28193090
PMCPMC5745576
OpenAlexW2588024821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.